Skip to main content

Table 2 Clinical information and treatment of 16 patients with recurrent PEMa

From: Clinical presentation of perineal endometriosis and prognostic nomogram after surgical resection

Recurrent cases, No

Number of lesions

Size of lesions, cm

ASIb

Preoperative GnRH-ac

Postoperative Hormone therapy

Disease-free interval, mo

Size of recurrent lesion, cm

Treatment for recurrence

1

2

2.0; 1.5

  

MPAd

72

2

Bilateral oophorectomy and total hysterectomy

2

1

2.5

 

Y

GnRH-a

96

3

Intravaginal radiation

3

2

5.0; 1.0

Y

 

GnRH-a

3

3

Surgical excision, GnRH-a

4

1

2.5

   

30

3

Surgical excision, GnRH-a

5

1

2

Y

Y

Gestrinone

3

2.5

Surgical excision, GnRH-a

6

2

3.5; 2.5

Y

Y

GnRH-a

60

1.5

GnRH-a, COCse

7

2

4.0; 1.0

Y

Y

GnRH-a

15

2

LNG-IUSf

8

2

2.0; 1.0

 

Y

COCs

24

1.5

GnRH-a, COCs

9

2

3.0; 1.5

Y

Y

 

36

2.0, rectum involved

Surgical excision, LNG-IUS

10

1

2.5

   

99

1.3

COCs

11

2

2.0; 1.0

Y

Y

LNG-IUS

6

3

GnRH-a, COCs, LNG-IUS

12

2

2.5; 1.0

  

GnRH-a

4

1

TCMg

13

1

3

Y

Y

GnRH-a

12

1.5

COCs

14

2

3.0; 2.0

Y

Y

 

12

2

COCs

15

1

3

Y

Y

GnRH-a

6

1

LNG-IUS

16

2

2.0; 0.5

 

Y

GnRH-a

26

3

Surgical excision, GnRH-a

  1. aPEM perineal endometriosis; bASI anal sphincter involvement; cGnRH-a gonadotrophin-releasing hormone agonist; dMPA medroxyprogesterone acetate; eCOCs combined oral contraceptives; fLNG-IUS levonorgestrel-releasing intra-uterine system; gTCM: traditional chinese medicine